FDA Releases Guidance to Mitigate Risk of Tuberculosis Transmission Through Human Cells and Tissues
January 07, 2025
January 07, 2025
WASHINGTON, Jan. 7 (TNSFR) -- The Food and Drug Administration (FDA) has issued new guidance aimed at reducing the risk of tuberculosis (TB) transmission through human cells, tissues, and cellular and tissue-based products (HCT/Ps). The guidance provides recommendations for establishments involved in donor eligibility determinations to screen for Mycobacterium tuberculosis (Mtb), the bacterium responsible for TB.
It also advises these establishments on additional precautionary meas . . .
It also advises these establishments on additional precautionary meas . . .